Concepedia
Statistics
Publications
8
Citations
493
H-Index
Active since
2011
Affiliations
GlaxoSmithKline (Spain)(Current)
GlaxoSmithKline (United States)
Medicines for Malaria Venture
GlaxoSmithKline (Germany)
GlaxoSmithKline (France)
Lourdes Rueda is an author at GlaxoSmithKline (Spain) specializing in drug discovery, pharmacology, and medicinal chemistry.
Publications per year
2011–2022
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia
Melissa B. Pappalardi, Kathryn Keenan, Mark Cockerill et al. · Nature Cancer · 2021 · 280 citations · Full text
Medicine, Oncology, Pharmacology +8
<i>In vitro</i> and <i>in vivo</i> induction of fetal hemoglobin with a reversible and selective DNMT1 inhibitor
Aidan G. Gilmartin, Arthur Groy, Elizabeth R. Gore et al. · Haematologica · 2020 · 68 citations · Full text
Medicine, Hematology, Pharmacology +12
Development of Chemical Entities Endowed with Potent Fast-Killing Properties against <i>Plasmodium falciparum</i> Malaria Parasites
Alexios N. Matralis, Adnan Malik, Maria Penzo et al. · Journal of Medicinal Chemistry · 2019 · 31 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +13
Structural characterization of dicyanopyridine containing DNMT1-selective, non-nucleoside inhibitors
J.R. Horton, Sarath Pathuri, Kristen Wong et al. · Structure · 2022 · 31 citations · Full text
Medicine, Medicinal Chemistry, Molecular Biology +17
Cyclopropyl Carboxamides: A New Oral Antimalarial Series Derived from the Tres Cantos Anti-Malarial Set (TCAMS)
Lourdes Rueda, Isabel Castellote, Julia Castro‐Pichel et al. · ACS Medicinal Chemistry Letters · 2011 · 29 citations
Medicine, Medicinal Chemistry, Pharmacology +16
1–5 of 8